You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: February 29, 2020

DrugPatentWatch Database Preview

Details for Patent: 6,110,940

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,110,940
Title: Salts of an anti-migraine indole derivative
Abstract:The present invention relates to hydrobromide salts of 3-(N-methyl-2(R)-pyrrolidinylmethyl)-5-(2-phenylsulphonylethyl)-1H-indole having the formula (I): ##STR1##
Inventor(s): Harding; Valerie Denise (Sandwich, GB), Macrae; Ross James (Sandwich, GB), Ogilvie; Ronald James (Sandwich, GB)
Assignee: Pfizer Inc. (New York, NY)
Application Number:08/776,680
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,110,940
Patent Claim Types:
see list of patent claims
Compound; Use; Composition; Process; Formulation;

Drugs Protected by US Patent 6,110,940

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,110,940

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9417310Aug 27, 1994
PCT Information
PCT FiledMay 17, 1995PCT Application Number:PCT/EP95/01914
PCT Publication Date:March 07, 1996PCT Publication Number: WO96/06842

International Family Members for US Patent 6,110,940

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 576   Start Trial
African Regional IP Organization (ARIPO) 9500754   Start Trial
Austria 163182   Start Trial
Australia 2735295   Start Trial
Australia 691005   Start Trial
Bulgaria 101250   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.